A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
Clinical trial NCT04171700 · TERMINATED
Trial details
- NCT number
- NCT04171700
- Sponsor
- pharmaand GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2022-06-08
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.